Patents by Inventor Cecile ESCUDERO

Cecile ESCUDERO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intratumoral administration of sirolimus for treatment of prostate cancer
    Patent number: 11013731
    Abstract: The present disclosure relates to methods of treating prostate cancer by administering an effective amount of sirolimus locally to the prostate of a subject in need thereof. In particular, the present disclosure provides methods of treating prostate cancer by intratumoral injection of a liquid formulation comprising sirolimus in which the amount of sirolimus administered is well above the dosage used for preventing transplant rejection.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: May 25, 2021
    Assignee: Santen Pharmaceutical Co., Ltd.
    Inventors: Aishwarya Kundu, Cecile Escudero, Sreenivasu Mudumba
  • INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER
    Publication number: 20190343821
    Abstract: The present disclosure relates to methods of treating prostate cancer by administering an effective amount of sirolimus locally to the prostate of a subject in need thereof. In particular, the present disclosure provides methods of treating prostate cancer by intratumoral injection of a liquid formulation comprising sirolimus in which the amount of sirolimus administered is well above the dosage used for preventing transplant rejection.
    Type: Application
    Filed: December 29, 2017
    Publication date: November 14, 2019
    Applicant: Santen Pharmaceutical Co., Ltd.
    Inventors: Aishwarya KUNDU, Cecile ESCUDERO, Sreenivasu MUDUMBA